Polymorphism in Fas Promoter Region Associated with Risk to Breast Cancer

Journal of Hunan Normal University(Medical Science) ›› 2015, Vol. 12 ›› Issue (2) : 4-7.

PDF(1812 KB)
PDF(1812 KB)
Journal of Hunan Normal University(Medical Science) ›› 2015, Vol. 12 ›› Issue (2) : 4-7.

Polymorphism in Fas Promoter Region Associated with Risk to Breast Cancer

Author information +
History +

Abstract

Objective To evaluate the association between polymorphisms in Fas promoter region and susceptibility to breast cancer. Methods In the case-control study, we genotyped Fas-670A/G and Fas-1377A/G by PCR-RFLP in 214 patients with breast cancer and 204 healthy controls. Results were analyzed using Chi-square test. Fas gene expression wwas detected by q-RT-PCR in breast cancer. Results The distribution of Fas-670A/G genotype and allele type was significant difference between the patients and healthy controls. Subjects with GG genotype significantly increased the risk of breast cancer compared with the individuals carrying AA and AG genotype. Fas expression level in subjects with breast cancer was significantly increased compared with the healthy control. And the Fas expression in subjects with GG genotype was significantly higher than that in subjects with AA, GG genotypes. Conclusion Fas expression significantly increased in breast cancer. Fas was regulated by Fas-670A/G and significantly associated with susceptibility to breast cancer. GG genotype enhanced Fas expression and increased the risk to breast cancer.

Key words

breast cancer / Fas / SNP / gene expression

Cite this article

Download Citations
Polymorphism in Fas Promoter Region Associated with Risk to Breast Cancer[J]. Journal of Hunan Normal University(Medical Science). 2015, 12(2): 4-7

References

[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer
[J]. Clin, 2011, 1(2): - 0.
[2] Cao W, Wang X, Li J. Hereditary Breast Cancer in the Han Chinese
Population[ J].Epidemiol, 201 , 2 (2): 5- .
[ ] Muschen M , Warskulat U, Beckmann MW, et al. Defining CD 5 as a
tumor suppressor gene[ J]. Mol Med, 2000, ( ): 12- 25.
[ ] Huang QR, Morris D, Manolios N et al. Identification and characterization
of polymorphisms in the promoter region of the human Apo-1/
FAS(CD 5) gene[J]. Molecular Immunology, 1 , ( - ): 5 -5 2
[5] 胡英, 黄欣, 王秀娟,等. Fas- 0 基因多态与青海地区乳腺癌风险
的关系[J].广东医学, 201 , (1 ):20 -20 .
[ ] 张柏林, 孙瞳, 刘海洁,等. FAS和FASL基因多态性增加乳腺癌发病
风险[J].中国医药导刊, 200 , 11(12):20 -20 .
[ ] 许晔琼, 何帮顺, 邓齐文,等. Fas/FasL 基因多态性与乳腺癌发生的
相关性[J].临床检验杂志, 201 , 1(12): 1- .
[ ] 杨文武, 刘元姣, 张蔚,等. Fas/FasL在肿瘤免疫逃逸中作用的研究
进展[J].实用癌症杂志, 2002, 1 ( ): - .
[ ] Natoli G, Ianni A ,Co stanzo A , et al. Resistance to F as mediated
apoptosis in human hepatoma cells[J]. Oncogene, 1 5, 11 ( ):
115 -11 .
[10] 陈云波, 王心明, 姜瑛,等. 可溶性Fas(sFas)对乳腺癌发生发展中的
影响[J].中国实验诊断学, 200 , 10( ): - 2.
[11] 黄国民, 佟芷宜, 乔士兴,等. 乳腺癌患者血清可溶性Fas水平变化
及其意义[J].中国实验诊断学, 200 , 11(1):5 -5 .
PDF(1812 KB)

Accesses

Citation

Detail

Sections
Recommended

/